Besins Hlthcare Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BESINS HLTHCARE, and when can generic versions of BESINS HLTHCARE drugs launch?
BESINS HLTHCARE has two approved drugs.
There are eight US patents protecting BESINS HLTHCARE drugs.
There are thirty-six patent family members on BESINS HLTHCARE drugs in twenty-nine countries.
Summary for Besins Hlthcare
| International Patents: | 36 |
| US Patents: | 8 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 2 |
Drugs and US Patents for Besins Hlthcare
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Besins Hlthcare | ANDROGEL | testosterone | GEL;TRANSDERMAL | 022309-002 | Sep 7, 2012 | DISCN | Yes | No | 8,466,137 | ⤷ Subscribe | ⤷ Subscribe | ||||
| Besins Hlthcare | ANDROGEL | testosterone | GEL;TRANSDERMAL | 021015-001 | Feb 28, 2000 | AB1 | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Besins Hlthcare | ANDROGEL | testosterone | GEL;TRANSDERMAL | 022309-003 | Sep 7, 2012 | AB2 | RX | Yes | No | 8,754,070 | ⤷ Subscribe | Y | ⤷ Subscribe | ||
| Besins Hlthcare | ANDROGEL | testosterone | GEL;TRANSDERMAL | 022309-003 | Sep 7, 2012 | AB2 | RX | Yes | No | 8,741,881 | ⤷ Subscribe | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Besins Hlthcare
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Besins Hlthcare | ANDROGEL | testosterone | GEL;TRANSDERMAL | 021015-002 | Feb 28, 2000 | 9,132,089*PED | ⤷ Subscribe |
| Besins Hlthcare | ANDROGEL | testosterone | GEL, METERED;TRANSDERMAL | 021015-003 | Sep 26, 2003 | 9,132,089*PED | ⤷ Subscribe |
| Besins Hlthcare | ANDROGEL | testosterone | GEL;TRANSDERMAL | 022309-002 | Sep 7, 2012 | 9,132,089*PED | ⤷ Subscribe |
| Besins Hlthcare | ANDROGEL | testosterone | GEL, METERED;TRANSDERMAL | 022309-001 | Apr 29, 2011 | 6,503,894*PED | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for BESINS HLTHCARE drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Gel | 1.62% | ➤ Subscribe | 2012-04-06 |
| ➤ Subscribe | Gel Metered-dose Pump | 1% | ➤ Subscribe | 2008-12-19 |
| ➤ Subscribe | Gel | 1.62% (1.25 g and 2.5 g packets) | ➤ Subscribe | 2013-06-19 |
International Patents for Besins Hlthcare Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Cyprus | 1113737 | ⤷ Subscribe |
| Tunisia | SN08167 | ⤷ Subscribe |
| Hong Kong | 1117417 | ⤷ Subscribe |
| World Intellectual Property Organization (WIPO) | 2007044976 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
